ABSTRACT
Since the 1990s positron-emission tomography (PET) in Germany has been used increasingly in clinical diagnostics in the areas of oncology, cardiology, and neurology/ psychiatry. As the use of PET requires a complex and expensive infrastructure, analysis of the cost-effectiveness of PET compared to common diagnostic methods is becoming increasingly important. This contribution summarizes and discusses the results of a health technology assessment report on the cost-effectiveness of PET.
ABSTRACT
Since the nineties positron emission tomography (PET) has been increasingly used in clinical diagnostics in the area of oncology, cardiology, and neurology/psychiatry in Germany. As the use of PET requires a complex and expensive infrastructure, analysis of the cost-effectiveness of PET compared to common diagnostic methods is becoming increasingly important. This article summarizes and discusses the results of a report on cost-effectiveness studies on PET.
